PSNL - Personalis, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
20.31
-2.26 (-10.01%)
At close: 4:00PM EDT

20.52 +0.21 (1.03%)
After hours: 7:47PM EDT

Stock chart is not supported by your current browser
Previous Close22.57
Open22.44
Bid20.21 x 900
Ask20.48 x 1000
Day's Range20.22 - 22.75
52 Week Range20.22 - 31.88
Volume823,379
Avg. Volume874,561
Market Cap604.247M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-6.57
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Top Stocks That Aren't On Wall Street's Radar
    Motley Fool12 days ago

    3 Top Stocks That Aren't On Wall Street's Radar

    Wall Street might be overlooking these intriguing investing opportunities.

  • Business Wire24 days ago

    Personalis Announces Closing of Initial Public Offering and Exercise in Full of Over Allotment Option

    Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the closing of its initial public offering of 9,109,725 shares of common stock at a public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,188,225 additional shares of common stock. All of the shares of common stock were offered by Personalis. Personalis estimates net proceeds from the offering to be approximately $140.8 million, after deducting underwriting discounts and commissions and estimated offering expenses.

  • Benzinga28 days ago

    Personalis IPO: What You Need To Know

    Data analytics in the biotech realm comes in the form of genomic sequencing – the process of determining the complete DNA sequence of an organism's genome, which helps in developing personalized and targeted ...

  • Business Wire28 days ago

    Personalis Prices Initial Public Offering of Common Stock

    Personalis, Inc., a leader in advanced genomics for cancer, today announced the pricing of its initial public offering of 7,921,500 shares of common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by Personalis. In addition, Personalis has granted the underwriters a 30-day option to purchase up to an additional 1,188,225 shares of common stock from Personalis at the public offering price less underwriting discounts and commissions.

  • Benzingalast month

    IPO Outlook For The Week: Biotechs And A Grocery Outlet

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Stoke Therapeutics, Inc. (STOK) will issue 6.7 million shares between ...